Friday, July 7, 2023 Daily Archives

Syngene adding biologics capacity through $86m Stelis plant

by

The facility in Bangalore, India – initially built to manufacture COVID vaccines – will bring Syngene International 20,000 liters of installed biologics drug substance capacity. Stelis Biopharma’s Unit 3 in Bangalore began life as a dedicated plant for the production of Covid vaccine Sputnik Light, but following decreased demand due to both the wain of the pandemic and the Russia-Ukraine conflict, parent company Strides has agreed to offload the plant. Syngene, a subsidiary of Biocon, announced it is to add…

July 7, 2023

Just-Evotec awarded $74m DOD mAb contract

by

Just-Evotec Biologics has won a deal worth $74 million with the Department of Defense (DOD) to develop mAb-based drug products for orthopoxviruses. Under the terms of the deal, Just-Evotec will develop drug product prototypes for Phase I clinical trials. The firm said its discovery activities will include finding monoclonal antibodies (mAbs) using artificial intelligence (AI)-based antibody de novo design to target orthopoxviruses, such as smallpox. “We have not disclosed the name or number of the different orthopoxviruses that will be…

July 7, 2023